Skip to main content

Ambu Value Stock - Dividend - Research Selection

Ambu A/S

ISIN: DK0060946788, WKN: A2JAHY

Market price date: 18.01.2022
Market price: 139,75 DKK


Ambu A/S Fundamental data and company key figures of the share

Annual reports in DKK
Key figures 10-09-2021
Cash flow
Net operating cash flow 295.000.000
Capital Expenditures -144.000.000
Free cash flow 151.000.000
Balance sheet
Total Equity 2.372.000.000
Liabilities & Shareholders equity 4.926.000.000
Income statement
Net income 241.000.000
Eps (diluted) 0,972
Diluted shares outstanding 247.913.000
Net sales/revenue 3.567.000.000

Fundamental ratios calculated on: 18-01-2022

Ratios
Key figures 18-01-2022
Cash flow
P/C 117,44
   
P/FC 229,44
Balance sheet
ROI4,89
ROE48,15
Income statement
P/E143,76
Div. Yield0,21%
P/B14,61
P/S9,71


Do you want to do make a detailed fundamental analysis of this stock?

✓ NEW Fundamental API Access to 500 data points per month
Fundamental data up to 25 years
Comparison to all other stocks by the FScore
Time saving!

How our site works ...

Non-binding 7 days without automatic subscription
 No termination required after the free week
Finanzoo fundamental analysis
Data updated daily
Virtual depots
Share alarms via email
Subscription can be canceled at any time at the end of the month 
Choice of desired shares
Over 2000 stock analyzes available
Bitcoin payment possible if you do not want to subscribe

Price for monthly subscription $ 19.99 / month including VAT.



DescriptionData
SymbolAMBU-B.CO
Market Capitalization4.907.412.480,00 USD
CountryDenmark
IndicesSTOXX EUROPE 600
SectorsHealth Care Equipment
Raw Data SourceIFRS in Millionen DKK
Stock Split2018-01-03,5.000000/1.000000; 2014-12-23,4.000000/1.000000; 2005-03-01,2.000000/1.000000; 2004-02-10,10.000000/1.000000
Internetwww.ambu.com


Description of the company

Ambu A/S develops, manufactures, and sells medical devices to hospitals, clinics, and rescue services worldwide. It provides healthcare solutions in the fields of visualization, anesthesia, and patient monitoring and diagnostics. The company offers endoscopy products, such as bronchoscopes and monitors, as well as related airway management products comprising video laryngoscopes, double and single lumen tubes, and endobronchial blockers; and neurology products, including EEG and EMG electrodes, EMG guided injections, and intraoperative monitoring products. It also provides cardiology products consisting of ECG electrodes; and airway management and anaesthesia products, such as bronchoscopes, video laryngoscopes, double and single lumen tubes, endobronchial blockers, laryngeal and face masks, breathing bags, and resuscitators. In addition, the company offers resuscitators, extrication collars, head immobilizers, CPR breathing barriers, suction pumps, video laryngoscopes, and training manikins. It serves hospitals, rescue services, clinics, etc. Ambu A/S was founded in 1937 and is headquartered in Ballerup, Denmark.

The Finanzoo GmbH assumes no liability for the accuracy of the information! All information is provided without warranty. Sources:: www.bundesanzeiger.de, www.sec.gov, www.ambu.com


NEWS